Cargando…
Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application
Patients with biliary tract cancer (BTC) show different responses to chemotherapy, and there is no effective way to predict chemotherapeutic response. We have generated 61 BTC patient-derived organoids (PDOs) from 82 tumors (74.4%) that show similar histological and genetic characteristics to the co...
Autores principales: | Ren, Xiaoxue, Huang, Mingle, Weng, Weixiang, Xie, Yubin, Wu, Yifan, Zhu, Shenghua, Zhang, Ying, Li, Dongming, Lai, Jiaming, Shen, Shunli, Lin, Jie, Kuang, Ming, Li, Xiaoxing, Yu, Jun, Xu, Lixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694672/ https://www.ncbi.nlm.nih.gov/pubmed/37944531 http://dx.doi.org/10.1016/j.xcrm.2023.101277 |
Ejemplares similares
-
Mechanistic insight of SARS-CoV-2 infection using human hepatobiliary organoids
por: Zhao, Yi, et al.
Publicado: (2023) -
Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
por: Wang, Zhiwei, et al.
Publicado: (2021) -
The potential of patient-derived organoids in precision medicine of biliary tract cancer
por: Yáñez-Bartolomé, Mariana, et al.
Publicado: (2023) -
Oncogenic KRAS–expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice
por: Kasuga, Akiyoshi, et al.
Publicado: (2021) -
Establishment and Long-Term Culture of Organoids Derived from Human Biliary Tract Carcinoma
por: Saito, Yoshimasa, et al.
Publicado: (2020)